HB 831: Medication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report. Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request. The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.

Sponsors

Sponsors by party (alphabetical): Republican 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. February 18, 2026Left in Committee Rules
2. January 23, 2026Subcommittee recommends laying on the table (5-Y 0-N)
3. January 23, 2026House subcommittee offered
4. January 22, 2026Assigned HRUL sub: Studies Subcommittee
5. January 13, 2026Referred to Committee on Rules
6. January 13, 2026Prefiled and ordered printed; Offered 01-14-2026 26103422D